Revatrol Claims Misleading – NAD
This article was originally published in The Tan Sheet
Executive Summary
Renaissance Health Publishing's advertising claims that indicate the benefits of its Revatrol dietary supplement are backed by scientific research are unfounded, the National Advertising Division of the Council of Better Business Bureaus says. NAD calls for discontinuing some print and online claims that appear to link Revatrol to recent research indicating the product's resveratrol ingredient to be an effective antioxidant. NAD challenged online claims that read "The #1 Red Wine Extract Formula," and "It's a powerful combination of the strongest available whole red wine grape extract," and print ads headlined with "National Health News Report" because the studies submitted by Renaissance were conducted on animal rather human subjects. The Boca Raton, Fla.-based supplement firm can state the proven benefits of the product's ingredients, but not imply those benefits have been proven for the product itself. Renaissance said it will modify the claims as recommended, although it disagrees with NAD's findings...
You may also be interested in...
Second EU MDR Notified Body Designated In France
Four years after the designation of the first notified body in France under the Medical Device Regulation, AFNOR Certification has been named too.
Takeda, Astellas Found New JV To Support Japanese Bioventures
Major Japanese companies Takeda, Astellas and SMBC are joining hands to establish a new joint venture with $3.9m capital and based in Japan’s largest biocluster Shonan iPark to help incubate local biopharma start-ups.
Could Eledon’s Anti-CD40L Change Transplant Medicine?
Eledon Pharmaceuticals’ CD40 Ligand blocker has yielded impressive results for post-transplant immunosuppression and cutting-edge transplant doctors have also used it for pig-to-human kidney and heart transplants, opening up the field of xenotransplantation.